Newscope Capital Corporation is a Canada-based specialty life sciences company. Through its subsidiary, PharmaTher Inc., it is focused on repurposing psychedelic-derived drugs with artificial intelligence (AI). Its product pipeline focuses on infectious diseases and rare disorders in pain and central and peripheral nervous systems. It offers panaceAI, which is an artificial intelligence drug repurposing platform.